Standard Biotools (LAB) Other Non-Current Assets (2010 - 2026)

Standard Biotools (LAB) has 17 years of Other Non-Current Assets data on file, last reported at $3.4 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 47.96% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 47.96% decrease from a year earlier, with the FY2025 full-year figure at $228.4 million, up 24.52% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $3.4 million, down from $228.4 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for LAB reached as high as $228.4 million in Q4 2025 and fell as low as $2.3 million in Q4 2023.
• Historically, Other Non-Current Assets has averaged $30.5 million across 5 years, with a median of $3.4 million in 2026.
• Across the five-year window, Other Non-Current Assets surged 7927.66% in 2024 and tumbled 47.96% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $3.1 million in 2022, then dropped by 26.5% to $2.3 million in 2023, then jumped by 7927.66% to $183.4 million in 2024, then climbed by 24.52% to $228.4 million in 2025, then slumped by 98.52% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $3.4 million in Q1 2026, $228.4 million in Q4 2025, and $6.5 million in Q1 2025.